Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 2b    crawled date : 2022 - 10 - 26    save search

Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ANIX | $3.1 0.98% 0.97% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 10.38% C: 9.62%

vaccine breast trial cancer phase 2b
eFFECTOR Therapeutics Completes Enrollment in Second of Three Cohorts of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
Published: 2022-10-26 (Crawled : 12:20) - globenewswire.com
EFTR | $1.82 -6.19% -6.59% 110K twitter stocktwits trandingview |
| | O: -0.33% H: 6.4% C: 4.7%

covid-19 treatment trial therapeutics phase 2b
Hepion Pharmaceuticals Announces Publication of Phase 2a ‘AMBITION’ Clinical Trial Results
Published: 2022-10-26 (Crawled : 12:20) - contravir.com
HEPA | $1.39 -6.71% -7.19% 37K twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 10.51% C: 9.16%

pharmaceuticals trial results publication phase 2b
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - nutriband.com
NTRB | $3.56 -8.76% 3.4K twitter stocktwits trandingview |
Manufacturing
| | O: 0.24% H: 10.71% C: -0.95%
SRNE | $0.015 -8.85% 56K twitter stocktwits trandingview |
Health Technology
| | O: -3.14% H: 10.39% C: 3.25%

conference therapeutics study phase 2b
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. with Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - biospace.com/
NTRB | $3.56 -8.76% 3.4K twitter stocktwits trandingview |
Manufacturing
| | O: 0.24% H: 10.71% C: -0.95%
SRNE | $0.015 -8.85% 56K twitter stocktwits trandingview |
Health Technology
| | O: -3.14% H: 10.39% C: 3.25%

conference therapeutics study phase 2b
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.